Concepedia

Machiko Shiroishi

MS

Statistics

Publications

3

Citations

180

H-Index

3

Active since

2017

Affiliations

Daiichi-Sankyo (Japan)(Current)

Machiko Shiroishi is an author at Daiichi-Sankyo (Japan) specializing in oncology, medicine, and molecular oncology.

Publications per year

2017–2023

3

Publications

3

Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor

Daisuke Honma, Osamu Kanno, Jun Watanabe et al. · Cancer Science · 2017 · 139 citations · Full text

, , +17

A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression of acute leukemia with rearranged MLL1 or mutated NPM1

Masashi Numata, Noriyasu Haginoya, Machiko Shiroishi et al. · Cancer Cell International · 2023 · 29 citations · Full text

, , +13

DS-3201, a Potent EZH1/2 Dual Inhibitor, Demonstrates Antitumor Activity Against Non-Hodgkin Lymphoma (NHL) Regardless of EZH2 Mutation

Daisuke Honma, Emi Nosaka, Machiko Shiroishi et al. · Blood · 2018 · 12 citations

, , +8

1–3 of 3